Enhanced sialylation and in vivo efficacy of recombinant human α-galactosidase through in vitro glycosylation

Human α-galactosidase A (GLA) has been used in enzyme replacement therapy for patients with Fabry disease. We expressed recombinant GLA from Chinese hamster ovary cells with very high productivity. When compared to an approved GLA (agalsidase beta), its size and charge were found to be smaller and m...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sohn, Youngsoo, Lee, Jung Mi, Park, Heung-Rok, Jung, Sung-Chul, Park, Tai Hyun, Oh, Doo-Byoung
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Society for Biochemistry and Molecular Biology 2013
Ämnen:
Research Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4133871/
https://ncbi.nlm.nih.gov/pubmed/23527859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2013.46.3.192
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk